Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study

University Hospital Leuven, Belgium
Medical University of Lodz, Copernicus Memorial Hospital, Poland
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Cherkassy Regional Oncology Center, Ukraine
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Hospital das Clinicas da Faculdade de Medicina da USP, São Paolo, Brazil
University of Vienna, Vienna General Hospital, Austria
Masaryk University Hospital Brno, Czech Republic
Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Japan
Janssen Research & Development, LLC, Raritan, NJ, USA
Janssen Research & Development, High Wycombe, Buckinghamshire, UK
Janssen Research & Development, High Wycombe, Buckinghamshire, UK
Millennium Pharmaceuticals, Inc., Boston, MA, USA
Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Ticino, Switzerland
Vol. 102 No. 5 (2017): May, 2017